Health
Beckman Coulter Launches Semi-Quantitative Access SARS-CoV-2 IgG II Antibody Test – HospiMedica
Beckman Coulter Diagnostics (Brea, CA, USA) has launched its Access SARS-CoV-2 IgG II assay that measures a patient’s relative level of antibodies in response to…
Beckman Coulter Diagnostics (Brea, CA, USA) has launched its Access SARS-CoV-2 IgG II assay that measures a patients relative level of antibodies in response to a previous SARS-CoV-2 infection. The assays new capabilities enable clinicians to establish a baseline to evaluate an individuals immune response to the SARS-CoV-2 virus based on a numerical value and assess relative changes of an individuals immune response to the virus over time. The assay may also help researchers as they begin to understand…
-
General23 hours agoMatildas vs Panama international friendly — live blog and scores from Bunbury
-
General24 hours agoTariff letters to 12 countries going out Monday: Trump
-
General24 hours agoCan the world be governed without the US? • Inside Story
-
General23 hours agoWA road toll hits decade high as five people killed in 24 hours